Shallaki
| Product dosage: 60caps | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 2 | $26.50 | $53.00 (0%) | 🛒 Add to cart |
| 3 | $24.33 | $79.50 $73.00 (8%) | 🛒 Add to cart |
| 4 | $22.50 | $106.00 $90.00 (15%) | 🛒 Add to cart |
| 5 | $21.80 | $132.50 $109.00 (18%) | 🛒 Add to cart |
| 6 | $21.33 | $159.00 $128.00 (19%) | 🛒 Add to cart |
| 7 | $21.00 | $185.50 $147.00 (21%) | 🛒 Add to cart |
| 8 | $20.62 | $212.00 $165.00 (22%) | 🛒 Add to cart |
| 9 | $20.44 | $238.50 $184.00 (23%) | 🛒 Add to cart |
| 10 | $20.30
Best per bottle | $265.00 $203.00 (23%) | 🛒 Add to cart |
Synonyms | |||
More info:
Natural Joint Support with Shallaki Extract for Enhanced Mobility
Shallaki, derived from the resin of the Boswellia serrata tree, is a time-honored botanical extract with a robust profile in supporting joint health and inflammatory response. Known in Ayurvedic medicine as Indian frankincense, it contains active boswellic acids that target key pathways in the body’s inflammatory processes. This product card provides a comprehensive, evidence-based overview for healthcare professionals and informed consumers considering shallaki for therapeutic use. Features Standardized extract containing a minimum of 65% boswellic acids for consistent potency Sourced from sustainably harvested Boswellia serrata resin in accordance with traditional practices Produced in a cGMP-certified facility with third-party verification for purity and heavy metal screening Formulated without common allergens: gluten-free, soy-free, and non-GMO Available in 500mg vegetarian capsules for precise dosing and optimal bioavailability Benefits Supports healthy joint function and comfort by modulating inflammatory mediators like 5-LOX Promotes improved mobility and flexibility in individuals with age-related joint concerns Contributes to the management of occasional stiffness and discomfort associated with physical activity Aids in maintaining cartilage integrity through inhibition of matrix metalloproteinases Provides a natural, well-tolerated alternative to conventional support strategies Supports overall musculoskeletal wellness as part of a holistic health regimen Common use Shallaki is primarily utilized for its supportive role in musculoskeletal conditions, particularly those involving inflammatory components.
Rumalaya Gel: Targeted Relief for Musculoskeletal Pain and Inflammation
Rumalaya Gel is a topical analgesic and anti-inflammatory formulation designed for the symptomatic management of musculoskeletal conditions. As a polyherbal preparation, it leverages the synergistic actions of multiple botanical extracts to provide localized relief from pain, stiffness, and swelling associated with various orthopedic and rheumatic disorders. Its non-greasy, fast-absorbing base ensures efficient transdermal delivery of active constituents, making it a suitable option for patients seeking an adjunct or alternative to systemic medications.
Rumalaya: Comprehensive Herbal Support for Joint and Musculoskeletal Health
Rumalaya is a clinically-formulated polyherbal supplement designed to address the multifaceted nature of joint discomfort, inflammation, and musculoskeletal degeneration. It integrates a synergistic blend of traditional Ayurvedic herbs with modern pharmacological understanding to provide a holistic approach to managing rheumatic and osteoarthritic conditions. By targeting underlying inflammatory pathways while supporting structural integrity and mobility, Rumalaya offers a non-steroidal alternative for long-term musculoskeletal wellness. Its mechanism is rooted in both symptom alleviation and potential disease modification, making it a cornerstone in integrative rheumatological care.
Actoplus Met: Dual-Action Control for Type 2 Diabetes
Actoplus Met combines two proven antihyperglycemic agents, pioglitazone and metformin, into a single tablet to provide comprehensive glycemic management for adults with type 2 diabetes mellitus. This fixed-dose combination therapy targets two key pathophysiological defects of the disease—insulin resistance and hepatic glucose overproduction—offering a synergistic approach to lower both fasting and postprandial blood glucose levels. By addressing multiple mechanisms simultaneously, it can simplify treatment regimens and improve adherence, which is critical for long-term metabolic control and reducing the risk of diabetes-related complications.
Actos: Advanced Type 2 Diabetes Management with Pioglitazone
Actos (pioglitazone hydrochloride) is a thiazolidinedione-class oral antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. By enhancing insulin sensitivity in peripheral tissues, it addresses core pathophysiological defects associated with the disease. This medication is designed for long-term management, helping to stabilize blood glucose levels and potentially reduce the risk of diabetic complications when used as part of a comprehensive treatment plan under medical supervision.
Amaryl: Advanced Glycemic Control for Type 2 Diabetes
Amaryl (glimepiride) is a second-generation sulfonylurea oral antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It functions primarily by stimulating insulin secretion from the pancreatic beta cells. This medication is recognized for its once-daily dosing convenience and its role in comprehensive diabetes management strategies, often used both as monotherapy and in combination with other antihyperglycemic agents when needed.
Baclofen: Effective Muscle Spasticity Relief for Enhanced Mobility
Baclofen is a centrally-acting skeletal muscle relaxant primarily indicated for the management of muscle spasticity. It functions as a gamma-aminobutyric acid (GABA) derivative, specifically targeting GABA-B receptors within the spinal cord to inhibit monosynaptic and polysynaptic reflex transmission. This pharmacological action results in reduced muscle tone and frequency of spasms, offering significant symptomatic relief for patients with neurological conditions. Clinicians value baclofen for its targeted mechanism and well-established efficacy profile in both oral and intrathecal formulations.
Baclosign: Targeted Spasticity Relief with Precision Muscle Relaxation
Baclosign (baclofen) is a centrally acting skeletal muscle relaxant specifically formulated for the management of spasticity resulting from multiple sclerosis, spinal cord injuries, and other neurological diseases. It operates as a gamma-aminobutyric acid (GABA) agonist, primarily exerting its effect at the spinal cord level to inhibit monosynaptic and polysynaptic reflex transmission. This targeted mechanism reduces the frequency and amplitude of muscle spasms, alleviates associated pain, and improves range of motion, thereby facilitating daily activities and therapeutic regimens.
Colospa: Targeted Relief for Irritable Bowel Syndrome Discomfort
Colospa (mebeverine hydrochloride) is an antispasmodic agent specifically formulated for the symptomatic management of Irritable Bowel Syndrome (IBS). It functions as a direct smooth muscle relaxant, acting predominantly on the gastrointestinal tract to alleviate spasmodic pain and cramping without affecting normal gut motility. By targeting the underlying muscle hyperactivity responsible for discomfort, Colospa provides focused relief, helping to restore daily comfort and function for individuals affected by IBS. Its selective action minimizes systemic side effects, making it a well-tolerated option for long-term symptom control.